Page
%P
-
Article
Open AccessRetinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer
Retinoid X Receptor Gamma (RXRG) is a member of the nuclear receptor superfamily and plays a role in tumour suppression. This study aims to explore the prognostic significance of RXRG in breast cancer.
-
Article
Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer
CD133/ prominin 1 is a cancer stem cell marker associated with cancer progression and patient outcome in a variety of solid tumours, but its role in invasive breast cancer (BC) remains obscure. The current stu...